187 related articles for article (PubMed ID: 7027859)
1. Renal and electrolyte disturbances associated with cisplatin.
Blachley JD; Hill JB
Ann Intern Med; 1981 Nov; 95(5):628-32. PubMed ID: 7027859
[TBL] [Abstract][Full Text] [Related]
2. Renal salt wasting in patients treated with high-dose cisplatin, etoposide, and mitomycin in patients with advanced non-small cell lung cancer.
Lee YK; Shin DM
Korean J Intern Med; 1992 Jul; 7(2):118-21. PubMed ID: 1339077
[TBL] [Abstract][Full Text] [Related]
3. Mannitol to prevent cisplatin-induced nephrotoxicity in patients with squamous cell cancer of the head and neck (SCCHN) receiving concurrent therapy.
McKibbin T; Cheng LL; Kim S; Steuer CE; Owonikoko TK; Khuri FR; Shin DM; Saba NF
Support Care Cancer; 2016 Apr; 24(4):1789-93. PubMed ID: 26446698
[TBL] [Abstract][Full Text] [Related]
4. Effect of low-dose prophylactic dopamine on high-dose cisplatin-induced electrolyte wasting, ototoxicity, and epidermal growth factor excretion: a randomized, placebo-controlled, double-blind trial.
Somlo G; Doroshow JH; Lev-Ran A; Ahn DC; Hwang L; Raschko JW; Forman SJ; Margolin KA; Morgan RJ; Leong LA
J Clin Oncol; 1995 May; 13(5):1231-7. PubMed ID: 7738626
[TBL] [Abstract][Full Text] [Related]
5. A retrospective evaluation of furosemide and mannitol for prevention of cisplatin-induced nephrotoxicity.
Mach CM; Kha C; Nguyen D; Shumway J; Meaders KM; Ludwig M; Williams-Brown MY; Anderson ML
J Clin Pharm Ther; 2017 Jun; 42(3):286-291. PubMed ID: 28276070
[TBL] [Abstract][Full Text] [Related]
6. Cisplatin nephrotoxicity affects magnesium and calcium metabolism.
Goren MP
Med Pediatr Oncol; 2003 Sep; 41(3):186-9. PubMed ID: 12868117
[TBL] [Abstract][Full Text] [Related]
7. The role of mannitol as a nephroprotectant in patients receiving cisplatin therapy.
Morgan KP; Buie LW; Savage SW
Ann Pharmacother; 2012 Feb; 46(2):276-81. PubMed ID: 22298599
[TBL] [Abstract][Full Text] [Related]
8. Renal salt wasting in patients treated with cisplatin.
Hutchison FN; Perez EA; Gandara DR; Lawrence HJ; Kaysen GA
Ann Intern Med; 1988 Jan; 108(1):21-5. PubMed ID: 3337511
[TBL] [Abstract][Full Text] [Related]
9. Short hydration with 20 mEq of magnesium supplementation for lung cancer patients receiving cisplatin-based chemotherapy: a prospective study.
Hase T; Miyazaki M; Ichikawa K; Yogo N; Ozawa N; Hatta T; Ando M; Sato M; Kondo M; Yamada K; Hasegawa Y
Int J Clin Oncol; 2020 Nov; 25(11):1928-1935. PubMed ID: 32740717
[TBL] [Abstract][Full Text] [Related]
10. Characterizing the impact of magnesium and potassium-supplemented hydration with cisplatin and the subsequent electrolyte replacement requirements.
Uhm SJ; Meszaros E; Hammonds K; Patel I; Herrington JD
J Oncol Pharm Pract; 2021 Jul; 27(5):1125-1131. PubMed ID: 32799780
[TBL] [Abstract][Full Text] [Related]
11. Persisting renotubular sequelae after cisplatin in children and adolescents.
Bianchetti MG; Kanaka C; Ridolfi-Lüthy A; Hirt A; Wagner HP; Oetliker OH
Am J Nephrol; 1991; 11(2):127-30. PubMed ID: 1951473
[TBL] [Abstract][Full Text] [Related]
12. Nephrotoxicity induced by cancer chemotherapy with special emphasis on cisplatin toxicity.
Ries F; Klastersky J
Am J Kidney Dis; 1986 Nov; 8(5):368-79. PubMed ID: 3538860
[TBL] [Abstract][Full Text] [Related]
13. The ability of mannitol to decrease cisplatin-induced nephrotoxicity in children: real or not?
Ruggiero A; Rizzo D; Trombatore G; Maurizi P; Riccardi R
Cancer Chemother Pharmacol; 2016 Jan; 77(1):19-26. PubMed ID: 26589789
[TBL] [Abstract][Full Text] [Related]
14. Hydration with 15 mEq Magnesium Is Effective at Reducingthe Risk for Cisplatin-induced Nephrotoxicity in Patients Receiving Cisplatin (≥50 mg/m2) Combination Chemotherapy.
Yamamoto Y; Watanabe K; Tsukiyama I; Yabushita H; Matsuura K; Wakatsuki A
Anticancer Res; 2016 Apr; 36(4):1873-7. PubMed ID: 27069173
[TBL] [Abstract][Full Text] [Related]
15. The Effect of Intravenous Mannitol Combined With Normal Saline in Preventing Cisplatin-Induced Nephrotoxicity: A Randomized, Double-Blind, Placebo-Controlled Trial.
Sainamthip P; Saichaemchan S; Satirapoj B; Prasongsook N
JCO Glob Oncol; 2022 Mar; 8():e2100275. PubMed ID: 35436142
[TBL] [Abstract][Full Text] [Related]
16. [Pseudoparalysis induced by cancer chemotherapy (cis-platinum)].
Leclercq B; Escudier B; Tandonnet F; Conscience G; Roussignol E; Nitenberg G
Cah Anesthesiol; 1985; 33(1):23-4. PubMed ID: 4039623
[No Abstract] [Full Text] [Related]
17. Magnesium supplementation and high volume hydration reduce the renal toxicity caused by cisplatin-based chemotherapy in patients with lung cancer: a toxicity study.
Oka T; Kimura T; Suzumura T; Yoshimoto N; Nakai T; Yamamoto N; Matsuura K; Mitsuoka S; Yoshimura N; Kudoh S; Hirata K
BMC Pharmacol Toxicol; 2014 Dec; 15():70. PubMed ID: 25472655
[TBL] [Abstract][Full Text] [Related]
18. Mannitol for the prevention of cisplatin-induced nephrotoxicity: A retrospective comparison of hydration plus mannitol versus hydration alone in inpatient and outpatient regimens at a large academic medical center.
Williams RP; Ferlas BW; Morales PC; Kurtzweil AJ
J Oncol Pharm Pract; 2017 Sep; 23(6):422-428. PubMed ID: 27352615
[TBL] [Abstract][Full Text] [Related]
19. Magnesium depletion enhances cisplatin-induced nephrotoxicity.
Lajer H; Kristensen M; Hansen HH; Nielsen S; Frøkiaer J; Ostergaard LF; Christensen S; Daugaard G; Jonassen TE
Cancer Chemother Pharmacol; 2005 Nov; 56(5):535-42. PubMed ID: 15947931
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for cisplatin-induced nephrotoxicity and potential of magnesium supplementation for renal protection.
Kidera Y; Kawakami H; Sakiyama T; Okamoto K; Tanaka K; Takeda M; Kaneda H; Nishina S; Tsurutani J; Fujiwara K; Nomura M; Yamazoe Y; Chiba Y; Nishida S; Tamura T; Nakagawa K
PLoS One; 2014; 9(7):e101902. PubMed ID: 25020203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]